ES2067925T3 - Derivado del acido s-(2-tenoil)-tiolactico con actividad farmacologica. - Google Patents

Derivado del acido s-(2-tenoil)-tiolactico con actividad farmacologica.

Info

Publication number
ES2067925T3
ES2067925T3 ES91904932T ES91904932T ES2067925T3 ES 2067925 T3 ES2067925 T3 ES 2067925T3 ES 91904932 T ES91904932 T ES 91904932T ES 91904932 T ES91904932 T ES 91904932T ES 2067925 T3 ES2067925 T3 ES 2067925T3
Authority
ES
Spain
Prior art keywords
acid
tenoil
thylactic
derivative
pharmacological activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91904932T
Other languages
English (en)
Inventor
Giuseppe Quadro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yason SRL
Original Assignee
Yason SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yason SRL filed Critical Yason SRL
Application granted granted Critical
Publication of ES2067925T3 publication Critical patent/ES2067925T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UN COMPUESTO DE LA FORMULA (I) QUE SE PUEDE PREPARAR A BASE DE HACER REACCIONAR ACIDO S-(2-TENOIL)-TIOLACTICO CON ACIDO 4TIAZOLIDINCARBOXILICO QUE PRESENTA ACTIVIDADES INMUNOESTIMULANTES, ANTIOXIDANTES Y REGULADORAS DE LAS MUCOSIDADES.
ES91904932T 1990-03-05 1991-02-28 Derivado del acido s-(2-tenoil)-tiolactico con actividad farmacologica. Expired - Lifetime ES2067925T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19566A IT1241415B (it) 1990-03-05 1990-03-05 Derivato dell'acido s-(2-tenoil)-tiolattico ad attivita' farmacologica

Publications (1)

Publication Number Publication Date
ES2067925T3 true ES2067925T3 (es) 1995-04-01

Family

ID=11159124

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91904932T Expired - Lifetime ES2067925T3 (es) 1990-03-05 1991-02-28 Derivado del acido s-(2-tenoil)-tiolactico con actividad farmacologica.

Country Status (9)

Country Link
US (1) US5312825A (es)
EP (1) EP0518904B1 (es)
JP (1) JPH05504771A (es)
AT (1) ATE114652T1 (es)
CA (1) CA2077543A1 (es)
DE (1) DE69105489T2 (es)
ES (1) ES2067925T3 (es)
IT (1) IT1241415B (es)
WO (1) WO1991013883A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264446B1 (it) * 1993-05-14 1996-09-23 Yason Srl Acido 3 (n-(2-mercapto-propionil-ammino-acetil))-tetraidrotiazolil-4- carbossilico come agente antiinfiammatorio e immunostimolante

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT7851510A0 (it) * 1977-10-28 1978-10-16 Sandoz Ag Ammidi di amminoacidi ciclici loro preparazione e loro applicazione quali medicamenti
AU528115B2 (en) * 1978-04-08 1983-04-14 Santen Pharmaceutical Co. Ltd. Antihypertensive 4-thiazolidine/carboxylic acids
IT1143209B (it) * 1981-07-02 1986-10-22 Sigma Tau Ind Farmaceuti Esteri della 2-tenoilmercaptopropionil glicina con idrossibenzeni sostituiti procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
FR2532318B1 (fr) * 1982-08-31 1985-06-14 Rhone Poulenc Chim Base Procede de preparation de triarylphosphines sulfonees
IT1212723B (it) * 1983-03-23 1989-11-30 Medea Res Srl Derivato dell'acido tiolattico ad attivita'broncosecretogoga.
US5053414A (en) * 1988-04-08 1991-10-01 Ono Pharmaceutical Co., Ltd. Heterocyclic compounds

Also Published As

Publication number Publication date
DE69105489T2 (de) 1995-07-13
EP0518904B1 (en) 1994-11-30
JPH05504771A (ja) 1993-07-22
IT1241415B (it) 1994-01-14
EP0518904A1 (en) 1992-12-23
WO1991013883A1 (en) 1991-09-19
CA2077543A1 (en) 1991-09-06
US5312825A (en) 1994-05-17
IT9019566A0 (it) 1990-03-05
ATE114652T1 (de) 1994-12-15
DE69105489D1 (de) 1995-01-12
IT9019566A1 (it) 1991-09-05

Similar Documents

Publication Publication Date Title
ES469005A1 (es) Un procedimiento para la preparacion de nuevos derivados de somatostatina
ATE85057T1 (de) Optisch aktive pyridobenzoxazinderivate.
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
ES2106783T3 (es) 1-benzopiran-4-onas y 2-amino-1,3-benzoxacin-4-onas antiarterosclerosis y antitromboticas.
ES2040231T3 (es) Composiciones medicamentosas estables.
ES2104386T3 (es) Compuesto intermedio para la acitromicina.
ES2194003T3 (es) Huperzina a racemica.
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
ES2074431T3 (es) Un procedimiento para la sintesis de amicacina.
NO844291L (no) Griseolsyrederivater
ES2039195T3 (es) Derivado de la pirazolsulfonamida, procedimiento para su fabricacion y herbicida que lo contiene.
NO930203L (no) Polypeptidforbindelser med veksthormonfrigjoerende aktivitet
ES2067925T3 (es) Derivado del acido s-(2-tenoil)-tiolactico con actividad farmacologica.
AR241108A2 (es) Insecticidas piretroides, acidos ciclopropancarboxilicos y esteres intermediarios y sus precedimientos de preparacion
ES463424A1 (es) Procedimiento de preparacion de lactamas sustituidas en n.
ES456574A1 (es) Procedimiento de obtencion de pentametil-carbamato de quer- cetina.
ES2021515A6 (es) Procedimiento para la preparacion de compuestos derivados de isotiazolo-piridona azetidinil substituidos.
MX9202651A (es) Derivados de acido propenoico.
ES2135384T3 (es) Derivados de 1,4-dihidropiridina opticamente activos y procedimientos para producirlos.
ES2020174B3 (es) Procedimiento para preparar compuestos carbonilicos opticamente activos.
ES2004705A6 (es) Un procedimiento para preparar nuevos derivados del acido butenoico
EP0237271A3 (en) A sesquilignan derivative
SU1769405A1 (ru) Регулятор роста растений
SU1351063A1 (ru) Производные 2-тиазолзамещенного 5-нитрофурана, проявляющие антистафилококковую активность
SU1660376A1 (ru) N-диэтокситиофосфорил-1-метилмеркаптометилидентетрагидроизохинолин, обладающий акарицидной активностью

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 518904

Country of ref document: ES